Free Republic

16:36' 24/03/2008 (GMT+7) After four years of research, scientists at the National Institute for Hygiene and Epidemiology have announced they will test type A/H5N1 vaccine on humans this April and the vaccine will be available on the market in 2009. Last stage of H5N1 vaccine There was good news for scientists at the National Institute for Hygiene and Epidemiology: the Ministry of Health agreed to let them test H5N1 vaccine on humans. The over-four year process of researching H5N1 virus carried out by the scientists is at last in the final stage. In early March 2008, a group of scientists...

17:46' 04/04/2008 (GMT+7) Scientists inject the vaccine in monkeys on Reu Island, Quang Ninh province in 2004. Vaccine and Biomedical Product Company 1 on April 3 injected a second dose of H5N1 vaccine in ten volunteers. Vietnam to produce H5N1 vaccine in 2009This test aims to verify the safety of H5N1 vaccine in humans. After the injection, all volunteers were in normal condition. These people will be monitored for seven days more to ensure the safety of the vaccine. On March 6, these people took the first dose of type A/H5N1 vaccine and no abnormal symptoms were recorded before they...

(BEIJING) -- China's food and drug regulators on Wednesday authorized a domestic pharmaceutical firm to begin commercial production of a human bird flu vaccine, following more than two years of clinical trials. The firm, Beijing-based Sinovac Biotech Co., Ltd. will produce vaccines to defend humans against the H5N1 virus and its epidemic variety, making China the world's second country with the technology and industrial capacity to produce human bird flu vaccine. According to Yin Weidong, general manager of the firm, Sinovac has the ability to produce new vaccines even if the virus mutates in humans. China started clinical research and...